Harborside Inc. Announces Plaintiff’s Voluntary Dismissal of Class Action Suit Without Prejudice
Jan. 21, 2021
/PRNewswire/ – Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a
-focused, vertically-integrated cannabis enterprise, today announced that a complaint filed on
October 13, 2020
the United States
District Court, District of
(“the Court”), Case No. 3:20-cv-01551-MO, has been voluntarily dismissed in its entirety without prejudice.
The plaintiffs in this action had alleged violations of the U.S. Securities Exchange Act of 1934, more specifically alleging that the Company issued materially false and misleading statements during the class period. The plaintiff voluntarily dismissed, without prejudice, the above-captioned action against all defendants.
Harborside Inc. is one of the oldest and most respected cannabis retailers in
, operating three of the major dispensaries in the
San Francisco Bay Area
, a dispensary in the
area outfitted with
only cannabis drive-thru window, a dispensary in
and a cultivation/production facility in
. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of
consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in
the United States
and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the CSE trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at
The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:
SOURCE Harborside Inc.